Feedback / Questions
ixoberogene soroparvovec (ADVM-022) - Adverum Biotech
https://www.globenewswire.com/news-release/2025/04/15/3061610/32452/en/Adverum-Biotechnologies-Reports-Fourth-Quarter-and-Full-Year-2024-Financial-Results-and-Provides-Pipeline-Highlights-and-Updates-to-Anticipated-Milestones.html
Apr 15, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next